Obsessive-compulsive disorder (OCD) is characterized by recurrent intrusive thoughts and repetitive ritualistic actions. Although symptoms have long been considered symbolic expressions of unconscious issues, recent neuroscientific research has increasingly strengthened a conceptualization of OCD as a neuropsychiatric disorder. Thus, significant advances have been made in understanding both the neurochemical and the neuroanatomical underpinnings of OCD. Ongoing research of particular interest includes investigation of the neuroethology, neuroimmunology, and genetics of OCD. From a clinical perspective, research on OCD has resulted in increased recognition and more effective treatment of the condition, and has shed light on a range of other disorders with overlapping phenomenology. Of even broader interest, the study of OCD allows new insights on general questions in the study of brain-mind interrelationships. NEUROSCIENTIST 2:300-305, 1996
American Psychiatric Association.Diagnostic and statistical manual of mental disorders. 4th ed Washington DC: American Psychiatric Press1994.
2.
Rassmussen SA , Tsuang MTClinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry1986;143:317-322.
3.
Swedo S., Rapoport J., Leonard H., Lenane M., Cheslow D.Obsessive compulsive disorder in children and adolescents. I. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry1989;46:335-349.
4.
Esman AHPsychoanalysis and general psychiatry: obsessive-compulsive disorder as paradigm . J Am Psychoanal Assoc1989; 37:319-336.
5.
Zohar J., Insel TRObsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry1987;22:667-687.
6.
Jenike MAPharmacologic treatment of obsessive compulsive disorders. Psychiatr Clin North Am1992;15:895-919.
7.
Thoren P., Asberg M., Bertilsson L., et al. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. Arch Gen Psychiatry1980 ;37:1289-1294.
8.
Zohar J., Mueller EA, Insel TR, et al. Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls. Arch Gen Psychiatry1987:44;946-951.
9.
Hollander E. , DeCaria C., Nitescu A., et al. Serotonergic function in obsessive compulsive disorder: behavioral and neuroendocnne responses to oral m-CPP and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry1992;49:21-28.
10.
Zohar J., Insel TR, Zohar-Kadouch RC, et al. Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Arch Gen Psychiatry1988;45:167-172.
11.
Hollander E. , DeCaria C., Gully R., et al. Effects of chronic fluoxetme treatment on behavioral and neuroendocnne responses to meta-chlorophenylpiperazme in obsessive-compulsive disorder. Psychiatry Res1991;36:1-17.
12.
Pitman RK, Green RC, Jenike MA, et al. Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry1987;144:1166-1171.
13.
Hollander E. , Liebowitz MR, DeCaria C.Conceptual and methodological issues in studies of obsessive-compulsive and Tourette's disorders. Psychiatr Dev1989;4:267-296.
14.
Goodman WK, McDougle CJ, Price LH, et al. Beyond the serotomn hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry1990;Suppl 51:S36-S43.
15.
Frye PE, Arnold LEPersistent amphetamine-induced compulsive rituals: Response to pyridoxine (B6. Biol Psychiatry1981;16: 583-587.
16.
Borcherdmg BG , Keysor CS, Rapoport JL, et al. Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability ? Psychiatry Res1990;33:83-94.
17.
McDougle CJ, Goodman WK, Leckman JF, et al. Halopendol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry1994;51:302-308.
18.
Insel TR, Pickar D.Naloxone administration in obsessive-compulsive disorder: report of two cases . Am J Psychiatry1983;140: 1219-1220.
19.
Altemus M., Pigott T., Kalogeras K., et al. Abnormalities in the regulation of vasopressm and corticotrophm releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry1992;49:9-20.
20.
Leckman JF, Goodman WK, North WG, et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology1994;19:723-749.
21.
Neziroglu F. , Anemone R., Yaryura-Tobias JAOnset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry1992 ;149: 947-950.
22.
Stem DJ, Simeon D., Hollander E.Neurochemistry of obsessive-compulsive disorder. In: Hollander E, Stein DJ, editors. Obsessive-compulsive disorders: etiology, diagnosis, treatment . New York: Marcel Decker; in press.
23.
von Economo C.Encephalitis lethargica: its sequelae and treatment . London: Oxford University Press1931.
24.
Swedo SE, Rapoport JL, Cheslow DL, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry1989 ;146:246-249.
Hollander E. , Schiffman E., Cohen B., et al. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry1990;47:27-32.
27.
Luxenberg J. , Swedo S., Flament M., Friedland R., Rapoport J., Rapoport SINeuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry1988;145:1089-1093.
28.
Robinson D. , Wu H., Munne RA, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry1995;52:393-398.
29.
Insel TRToward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry1992;49:739-744.
30.
Khanna S.Obsessive-compulsive disorder: is there a frontal lobe dysfunction ? Biol Psychiatry1988;24:602-613.
31.
Garber HJ, Ananth JV, Chiu LC, Gnswold VJ, Oldendorf WHNuclear magnetic resonance study of obsessive-compulsive disorder . Am J Psychiatry1989;46:1001-1005.
32.
Martuza RL, Chiocca EA, Jenike MA, et al. Stereotactic radiofrequency thermal cingulotomy for obsessive-compulsive disorder. J Neuropsychiatry1990;2:331-336.
33.
Wise SP, Rapoport JLObsessive-compulsive disorder: is it basal ganglia dysfunction? In: Rapoport JL, editor. Obsessive-compulsive disorders m children and adolescents. Washington DC: American Psychiatric Press1989;327-344.
34.
Swedo SE, Leonard HL, Kiessling LSSpeculations on antmeuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics1994;93:323-326.
35.
Husby G., van de Rijn I., Zabriskie JB, Abdm AH, Williams RCAntibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med1976;144:1094.
36.
Bronze MS, Dale JBEpitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol1993;151:2820-2828.
37.
Hollander E. , Prohovmk I., Stem DJObsessions and cerebral blood flow during pharmacological challenge with m-CPP. J Neuropsychiatry Clin Neurosci1995;7:485-490.
38.
Stem DJ, Hollander E.The spectrum of obsessive-compulsive related disorders. In: Hollander E, editor. Obsessive-compulsive related disorders. Washington DC: American Psychiatric Press1993.
39.
Hollander E. , Liebowitz MR, Winchel R., et al. Treatment of bodydysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry1989;146:768-770.
40.
Fallon BA, Javitch J., Liebowitz MRHypochondriasis and OCD. Overlaps in diagnosis and treatment. J Clin Psychiatry1991;52: 457-460.
41.
Stem DJ, Simeon D., Cohen LJ, Hollander E.Tnchotillomania and obsessive-compulsive disorder. J Clin Psychiatry1995;4:28-34.
42.
Stem DJ, Hollander E., Liebowitz MRNeurobiology of impulsivity and impulse control disorders. J Neuropsychiatry Clin Neurosci1993;5:9-17.
43.
Stem DJ, Hollander E.Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry1992 ;53:123-126.
44.
Pauls DL, Towbm KE, Leckman JF, et al. Gilles de la Tourette's syndrome and obsessive compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry1986;43:1180-1182
45.
Malison RT, McDougle CJ, Van Dyck CH, et al. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry1995;152:1359-1361.
46.
Stein DJ, Shoulberg N., Helton K., Hollander E.The neuroethological model of obsessive-compulsive disorder. Compr Psychiatry1992;33:274-281.
47.
Rapoport JL , Ryland DH, Kriete M.Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. Arch Gen Psychiatry1992;48:517-521.
48.
Stein DJ, Dodman NH, Borchelt P., Hollander E.Behavioral disorders in veterinary practice: Relevance to psychiatry . Compr Psychiatry1994;35:275-285.
49.
Baer L., Minichiello WEBehavior therapy for obsessive-compulsive disorder. In: Jemke MA, Baer L, Minichiello WE, editors. Obsessive-compulsive disorders: theory and management. 2nd ed. Chicago: Year Book Medical Publishers1990.
50.
Baxter LR, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for OCD. Arch Gen Psychiatry1992;49:681-689.
51.
Stein DJ, Hollander E.Cognitive science and obsessive-compulsive disorder. In: Stem DJ, Young JE, editors. Cognitive science and clinical disorders. San Diego: Academic Press1992.
